微科研
连接会议、学者、机构、期刊的产学研服务平台
会议
会议目录
会议库
创建会议
会议投稿
联合办会
学者
学者目录
我的主页
机构
机构目录
创建机构
期刊
期刊目录
期刊入驻
期刊投稿
创办期刊
产学研
产学研资讯
发布供需
快速参会
创建会议
稿件处理
En
会议
学者
机构
期刊
产学研
快速参会
创建会议
稿件处理
科研
服务
Godefridus J. Peters
科研成果
20
论文成果
代表作品
优先展示有引用数据的代表论文。
代表文章
按发表年份排列。
1
nucleotidomics: Extending Reversed-Phase Metabolomics to Untargeted Nucleotide Analysis
ORCID
2026
2
Can the combination of 5-fluorouracil and gemcitabine increase the treatment efficacy of pancreatic and colon cancer?
ORCID
2026
3
Protein Kinase Inhibitors as Regulators of ABC Transporters in Overcoming Cancer Multidrug Resistance: A Comprehensive Review of Recent Advances
ORCID
2026
4
Evaluation of MTH1 and DCTPP1 inhibitors in fluorocyclopentenylcytosine (RX-3117) resistant lung cancer cells and potential cross resistance patterns
ORCID
2026
5
The Role of the Ecto-Nucleotidases CD73 and CD39 in Chemo- and Immunotherapy
ORCID
2026
6
Differential molecular mechanisms of bortezomib sensitization to rhTRAIL in non-small cell lung cancer cell lines
ORCID
2025
7
Obatoclax enhances TRAIL-induced apoptosis in non-small-cell-lung-cancer cells by increasing TRAIL receptor expression, priming for mitochondrial apoptosis and reducing XIAP levels
ORCID
2025
8
Effects of lactate dehydrogenase A and GLUT1 inhibition on human endothelial cell migration in relation to their intracellular nucleotide pool
ORCID
2024
9
Effects of nucleoside analogues, lipophilic prodrugs and elaidic acids on core signaling pathways in cancer cells
ORCID
2024
10
Evaluation of N⁴⁻hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry
ORCID
2024
11
Evaluation of the combination of gemcitabine, carboplatin, and lactate dehydrogenase A inhibitor on malignant mesothelioma
ORCID
2024
12
Looking for the unexpected in purine and pyrimidine metabolism
ORCID
2024
13
Novel mass spectrometry-based assay for thymidylate synthase activity
ORCID
2024
14
Obituary to Lynette Fairbanks, PhD
ORCID
2024
15
Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer
ORCID
2024
16
Nucleo(s)tide metabolism as basis for drug development; the Anne Simmonds award lecture
ORCID
2024
17
Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells
ORCID
2024
18
G-Protein Signaling Modulator 2 as a Potential Biomarker in Colorectal Cancer: Integrative Analysis Using Genetic Profiling and Pan-Cancer Studies
ORCID
2024
19
Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library( vol 938, 175395 , 2023)
ORCID
2024
20
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF₃B₁ Emerges as a Prognostic Indicator and Therapeutic Target
ORCID
2024
最后更新: 2026/10/13 20:54:53